UK markets closed

American Oriental Bioengineering, Inc. (AOBI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00050.0000 (0.00%)
At close: 01:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 124.08k
Enterprise value 89.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.00
Enterprise value/revenue 0.74
Enterprise value/EBITDA -3.10

Trading information

Stock price history

Beta (5Y monthly) 6.21
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 30.0005
52-week low 30.0005
50-day moving average 30.0005
200-day moving average 30.0005

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 572.99k
Implied shares outstanding 6145.98M
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (15 May 2012) 41.45k
Short ratio (15 May 2012) 4N/A
Short % of float (15 May 2012) 42.43%
Short % of shares outstanding (15 May 2012) 41.89%
Shares short (prior month 13 Apr 2012) 41.44k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:501
Last split date 303 Apr 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2012
Most-recent quarter (mrq)30 Sept 2013

Profitability

Profit margin -74.86%
Operating margin (ttm)-105.78%

Management effectiveness

Return on assets (ttm)-6.30%
Return on equity (ttm)-28.22%

Income statement

Revenue (ttm)121.58M
Revenue per share (ttm)1,660.67
Quarterly revenue growth (yoy)-39.20%
Gross profit (ttm)N/A
EBITDA -34.62M
Net income avi to common (ttm)-91.02M
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.23M
Total cash per share (mrq)44.27
Total debt (mrq)92.77M
Total debt/equity (mrq)32.70%
Current ratio (mrq)0.51
Book value per share (mrq)3,886.65

Cash flow statement

Operating cash flow (ttm)-31.24M
Levered free cash flow (ttm)-27.25M